Acelyrin Inc
(SLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 15,396 | 14,886 | 16,085 | 0 |
| Operating Income | -15,396 | -14,886 | -16,085 | N/A |
| Other Income | 990 | 412 | 0 | 0 |
| Pre-tax Income | -14,406 | -14,474 | -16,085 | 0 |
| Net Income Continuous | -14,406 | -14,474 | -16,085 | N/A |
| Net Income | $-14,406 | $-14,474 | $-16,085 | $N/A |
| EPS Basic Total Ops | -8.17 | -9.12 | -17.89 | N/A |
| EPS Basic Continuous Ops | -8.17 | -9.12 | -17.89 | N/A |
| EPS Diluted Total Ops | -8.17 | -9.12 | -17.89 | N/A |
| EPS Diluted Continuous Ops | -8.17 | -9.12 | -17.89 | N/A |
| EBITDA(a) | $-15,380 | $-14,886 | $-16,085 | $N/A |